Insights into an abnormally edited RNA molecule may yield new weapons against a hard-to-kill cancer

April 10, 2013
Unedited miR-376a* promotes aggressive tumor growth (dark red) in a mouse brain tumor model (top), whereas tumor growth (dark red) modulated by the edited form of the same microRNA, differing by a single base, is limited and non-invasive (bottom). Credit: 2013 A*STAR Institute of Bioengineering and Nanotechnology (top); Reproduced from Ref. 1; 2013 Y. Choudhury et al. (bottom)

Diagnosis of the brain cancer glioblastoma multiforme (GBM) is particularly bad news for patients due to limited available medical options and poor outcomes. Even treatments that can eliminate other malignancies, such as chemotherapy and surgery, buy only limited time for GBM patients.

"The disease usually recurs due to extensive invasion of into the normal and therapeutic resistance," explains Shu Wang of the A*STAR Institute of Bioengineering and Nanotechnology in Singapore. "This cancer's highly lethal nature results in a median survival time of around a year for patients with advanced GBM." As scientists hunt for effective treatments, research from Wang and colleagues could offer a useful strategy for fighting this deadly disease.

Rather than producing protein-coding messenger RNAs (mRNAs), some genes encode short 'microRNAs' that regulate other genes by binding target sequences on the mRNAs that they produce. Some microRNAs undergo further enzymatic 'editing', in which certain nucleotides are changed to inosine, and this 'A-to-I' modification can markedly alter a 's target preference. Since previous studies have indicated a link between abnormal mRNA editing and , Wang and co-workers investigated a group of mRNA-encoding genes known as the miR-376 cluster.

One product of this cluster, miR-376a*, typically undergoes A-to-I editing in healthy brain tissue. By analyzing primary tumor tissue as well as glioma-derived cell lines, the researchers determined that many GBM cells instead tend to carry the unedited form of miR-376a*. Importantly, a comparative analysis of patient tumors indicated that excessive levels of unedited miR-376a* are associated with considerably greater tumor volume (see image).

Follow-up studies by the team supported this connection. Relatively non-invasive glioma-derived cells became far more aggressive in culture when forced to express RNAs that mimic unedited miR-376a*; when transplanted into mice, these cells formed large, irregular tumors that soon killed their hosts. By comparison, cells expressing edited miR-376a* were comparatively quiescent, with limited tumor growth. Wang and co-workers also determined that unedited miR-376a* alters expression of a distinct subset of genes relative to its edited counterpart, some of which appear to contribute directly to its harmful effects.

"Introduction of a single base difference by adenosine-to-inosine 'mutation' in miR-376a* affects the selection of its target genes and redirects its function from inhibiting to promoting glioma cell invasion," says Wang. He adds that these results also highlight forced expression of edited miR-376a* as a possible GBM treatment strategy. He and his team are now exploring different delivery mechanisms for such a therapeutic intervention.

Explore further: Identification of a novel target for glioblastoma treatment

More information: Choudhury, Y. et al. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. The Journal of Clinical Investigation 122, 4059–4076 (2012). www.jci.org/articles/view/62925

Related Stories

Identification of a novel target for glioblastoma treatment

June 18, 2012
(Medical Xpress) -- A recent study from scientists at the Friedrich Miescher Institute for Biomedical Research has identified a novel target for the treatment of malignant brain tumors. The scientists found that the Mer receptor ...

Researchers say one specific microrna promotes tumor growth and cancer spread

April 3, 2013
Researchers at Moffitt Cancer Center have determined that the overexpression of microRNA-155 (miR-155), a short, single strand of ribonucleic acid encoded by the miR-155 host gene, promotes the growth of blood vessels in ...

MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients

February 5, 2013
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...

Potential new eye tumor treatment discovered

August 5, 2011
New research from a team including several Carnegie scientists demonstrates that a specific small segment of RNA could play a key role in the growth of a type of malignant childhood eye tumor called retinoblastoma. The tumor ...

Genetic switch shuts down lung cancer tumors in mice

October 25, 2012
Yale researchers manipulated a tiny genetic switch and halted growth of aggressive lung cancer tumors in mice and even prevented tumors from forming.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.